Due to a combination of a falling share price and several years of EPS growth, CLS's stock has de-rated form close to 50x to high-20 times P/E multiple (mid-20x if R&D expense is normalised).
That, combined with EPS growing in the high-teens means the multi-year under-performance of the stock has finally run its course, I think.
It's Hammer Time.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$263.65 |
Change
-0.300(0.11%) |
Mkt cap ! $127.5B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $264.45 | $259.33 | $83.98M | 320.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4 | $263.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $263.65 | 267 | 1 |
View Market Depth
| Last trade - 12.52pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |